Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 9.99
1.73 %
$ 1.28 B
Market Cap
-16.11
P/E
Price Target
Average
93.53%
Revenue Forecast
Estimate
17.03%
EBIT
Estimate
--11.96%
Net Income
Estimate
71.89%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
NeoGenomics, Inc.
Wall Street analysts predict an average 1-year price target for NEO of $19.3 , with forecasts ranging from
a
low of
$18 to a high of $21 .
NEO Lowest Price Target
Wall Street Target
18 USD
80.18%
NEO Average Price Target
Wall Street Target
19.3 USD
93.53%
NEO Highest Price Target
Wall Street Target
21 USD
110.21%
REVENUE FORECAST
Revenue Forecast Chart NEO
EBIT FORECAST
EBIT Forecast Chart NEO
NET INCOME FORECAST
Net Income Chart NEO